![[logo] US EPA](http://www.epa.gov/epafiles/images/logo_epaseal.gif){kind=logo}
Index of Cleared Science Reviews -
Terbuthylazine (PC Code 080814)
You will need Adobe Reader to view some of the files on this page. See EPA's PDF page
June 17, 1983. Memorandum. 22 Page(s).
Ed Budd. Toxicology Branch.
EPA Registration No. 40810-L. Belclene 319 (terbuthylazine, GS-13529).
Reviews of studies and interim reports submitted. Pages 2-5 removed,
pending registration action. Tox review 002994.
Document (1078 KB PDF).
September 15, 1983. Memorandum. 5 Page(s).
Edwin Budd. Toxicology Branch.
EPA Reg. No. 100-568. Terbuthylazine: submitted data demonstrating
previously unknown adverse effects.
Document (317 KB PDF).
June 24, 1986. Memorandum. 11 Page(s).
John Whalan. Toxicology Branch.
The Review of Toxicology and Mutagenicity Reports Pursuant to the
Registration of Terbuthylazine. EPA ID No. 40810-A. Acc. No. 259814. Tox
review 005210.
Document (878 KB PDF).
August 12, 1986. Memorandum. 19 Page(s).
Marcia Van Gemert. Toxicology Branch.
28-day Study in Rats Accession No. 262626. Pages 8-19 removed,
registrant data. Tox review 005339. Pages 8-19 removed, regisration
data.
Document (407 KB PDF).
August 18, 1986. Memorandum. 39 Page(s).
Marcia Van Gemert. Toxicology Branch.
28-day Dermal Toxicity Study in Rabbits Accession No. 263453. Pages
8-39 removed, registrant data. Tox review 005354.
Document (446 KB PDF).
April 15, 1987. Memorandum. 51 Page(s).
David Van Ormer. Toxicology Branch.
EPA Registration No. 40810-6 - TB proj. No. 1457 Terbuthylazine -
Chronic Toxicity/Oncogenicity Studies (2), Rat (Ciba-Geigy Nos. 785196
and 791229); and Chronic Toxicity/Oncogenicity Study, Mouse (No.
785915). Tox review 005834.
Document (2236 KB PDF).
May 27, 1988. Memorandum. 11 Page(s).
David Van Ormer. Toxicology Branch.
TB Project No. 8-0597; EPA ID No. 40810-6. Terbuthylazine: 28-Day Oral
and Dermal Toxicity Studies in Rabbits. MRID 405128-01.
Document (650 KB PDF).
October 30, 1991. Memorandum. 13 Page(s).
Henry Spencer. Toxicology Branch.
6(A) (2) Reregistration Special Review of a Developmental Toxicity Study
in Rats (Terbuthylazine) MRID 419627-01 Tox review 008742.
Document (791 KB PDF).
August 18, 1992. Memorandum. 2 Page(s).
John Redden. Toxicology Branch.
Requested review of "Supplement to a 28-day Dermal Toxicity Study in
Rabbits - Terbuthylazine - MRID 405148-02" MRID 420598-04 Tox
review 009678.
Document (84 KB PDF).
May 06, 1994. Memorandum. 24 Page(s).
Marion Copely. Toxicology Branch.
Terbuthylazine: Upgrade chronic studies and data base. Supplemental
DERs: 2-year chronic feeding/cancer, rat (83-5) (MRIDs 157342,
156486) and mouse (83-5) (MRID 156487). Pages 6-11 and 17-22
removed, registrant data. Tox review 010953.
Document (802 KB PDF).
May 18, 1994. Memorandum. 76 Page(s).
William Greear. Toxicology Branch.
TERBUTHYLAZINE. ID NO. 080814. Evaluation of Acute Toxicity and
Mutagenicity Studies; Upgrades/ Supplements for Mutagenicity and
Rabbit 28 Day Dermal Studies Submitted to Support Reregistration..
ToxR 010979. Pages 52-53, 64-76 removed, registrant dat.
Document (2609 KB PDF).
August 24, 1994. Memorandum. 17 Page(s).
William Greear. Toxicology Branch.
Carcinogenicity Peer Review of Terbuthylazine Tox review 011194.
Document (1144 KB PDF).
September 14, 1994. Review. 6 Page(s).
Marion Copely. Toxicology Branch.
Toxicology Endpoint Selection Document excerpt from Tox review
011288.
Document (442 KB PDF).
September 16, 1994. Memorandum. 11 Page(s).
Linea Hansen. Toxicology Branch.
TERBUTHYLAZINE. REREGISTRATION CASE NO. 2645. Toxicology
Chapter for the Reregistration Eligibility Document on Terbuthylazine.
excerpt of Tox review 011288.
Document (881 KB PDF).
September 20, 1994. Memorandum. 3 Page(s).
Linea Hansen. Toxicology Branch.
TERBUTHYLAZINE. ID NO. 080814. Response to Company
Reevaluation of Developmental Toxicity Study in Rabbit. Amendment to
Study Evaluation on Selection of NOEL/LOEL for Developmental Toxicity.
Exec Summary for Rabbit Dermal Tox review 011220.
Document (241 KB PDF).
October 13, 1994. Memorandum. 18 Page(s).
Charles Frick. Chemical Coordination Branch.
The HED Chapter of the Reregistration Eligibility Decision Document
(RED) for Terbuthylazine excerpt of Tox review 011288.
Document (1428 KB PDF).
*** End of Index for Terbuthylazine (PC Code 080814).